n-nor-3-(4'-iodophenyl)tropane-2-carboxylic acid methyl ester has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choe, YS; Kim, JH; Kim, SE; Lee, WY | 1 |
1 other study(ies) available for n-nor-3-(4'-iodophenyl)tropane-2-carboxylic acid methyl ester and Parkinson Disease
| Article | Year |
|---|---|
SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.
Topics: Adult; Aged; Aged, 80 and over; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Hypothalamus; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 1999 |